As of publication, CRO concept stocks have seen a sharp decline, with Baihua Pharmaceutical and Weilan Biology reaching their daily limit down. Chengda Pharmaceutical experienced a drop of over 10%, while Kanglong Chemical, Hongbo Pharmaceutical, and Sunshine Nuohe also witnessed significant falls.
